BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 10379196)

  • 1. Oxidized low-density lipoprotein enhances intimal thickening and alters vascular reactivity.
    Herman A; Matthys K; Van Hove C; Kockx M; Bult H
    Verh K Acad Geneeskd Belg; 1999; 61(1):19-36; discussion 36-8. PubMed ID: 10379196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exposure to oxidized low-density lipoprotein in vivo enhances intimal thickening and selectively impairs endothelium-dependent dilation in the rabbit.
    Matthys KE; Van Hove CE; Kockx MM; Andries LJ; Van Osselaer N; Herman AG; Bult H
    Cardiovasc Res; 1998 Jan; 37(1):239-46. PubMed ID: 9539879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local application of LDL promotes intimal thickening in the collared carotid artery of the rabbit.
    Matthys KE; Van Hove CE; Kockx MM; Andries LJ; Van Osselaer N; Herman AG; Bult H
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2423-9. PubMed ID: 9409211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of interleukin-1 beta and interleukin-1 receptor antagonist in oxLDL-treated human aortic smooth muscle cells and in the neointima of cholesterol-fed endothelia-denuded rabbits.
    Lin SJ; Yen HT; Chen YH; Ku HH; Lin FY; Chen YL
    J Cell Biochem; 2003 Mar; 88(4):836-47. PubMed ID: 12577317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of endothelin receptor antagonism in collar-induced intimal thickening and vascular reactivity changes in rabbits.
    Reel B; Ozkal S; Islekel H; Ozer E; Oktay G; Sozer GO; Tanriverdi S; Turkseven S; Kerry Z
    J Pharm Pharmacol; 2005 Dec; 57(12):1599-608. PubMed ID: 16354404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative modifications of LDL increase its binding to extracellular matrix from human aortic intima: influence of lesion development, lipoprotein lipase and calcium.
    Wang X; Greilberger J; Ratschek M; Jürgens G
    J Pathol; 2001 Sep; 195(2):244-50. PubMed ID: 11592105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidized low-density lipoproteins, autoantibodies against oxidized low-density lipoproteins and carotid intima media thickness in a clinically healthy population.
    Chen HW; Kuo CL; Huang CS; Kuo SJ; Liu CS
    Cardiology; 2008; 110(4):252-9. PubMed ID: 18073481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfer of 15-lipoxygenase gene into rabbit iliac arteries results in the appearance of oxidation-specific lipid-protein adducts characteristic of oxidized low density lipoprotein.
    Ylä-Herttuala S; Luoma J; Viita H; Hiltunen T; Sisto T; Nikkari T
    J Clin Invest; 1995 Jun; 95(6):2692-8. PubMed ID: 7769108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of lectin-like oxidized LDL receptor by oxidized LDL and lysophosphatidylcholine in cultured endothelial cells.
    Aoyama T; Fujiwara H; Masaki T; Sawamura T
    J Mol Cell Cardiol; 1999 Dec; 31(12):2101-14. PubMed ID: 10640439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-type natriuretic peptide (CNP) suppresses plasminogen activator inhibitor-1 (PAI-1) in vivo.
    Kairuz EM; Barber MN; Anderson CR; Kanagasundaram M; Drummond GR; Woods RL
    Cardiovasc Res; 2005 Jun; 66(3):574-82. PubMed ID: 15914122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma level of oxidized low-density lipoprotein is an independent determinant of coronary macrovasomotor and microvasomotor responses induced by bradykinin.
    Matsumoto T; Takashima H; Ohira N; Tarutani Y; Yasuda Y; Yamane T; Matsuo S; Horie M
    J Am Coll Cardiol; 2004 Jul; 44(2):451-7. PubMed ID: 15261947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-10 expression is positively correlated with oxidized LDL deposition and inversely with T-lymphocyte infiltration in atherosclerotic intimas of human coronary arteries.
    Sumiyoshi S; Nakashima Y; Chen YX; Itabe H; Sueishi K
    Pathol Res Pract; 2006; 202(3):141-50. PubMed ID: 16460885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel effect of oxidized low-density lipoprotein: cellular ATP depletion via downregulation of glyceraldehyde-3-phosphate dehydrogenase.
    Sukhanov S; Higashi Y; Shai SY; Itabe H; Ono K; Parthasarathy S; Delafontaine P
    Circ Res; 2006 Jul; 99(2):191-200. PubMed ID: 16778134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis and proliferation of endothelial cells in early atherosclerotic lesions: possible role of oxidised LDL.
    Norata GD; Tonti L; Roma P; Catapano AL
    Nutr Metab Cardiovasc Dis; 2002 Oct; 12(5):297-305. PubMed ID: 12616810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OxLDL upregulates caveolin-1 expression in macrophages: Role for caveolin-1 in the adhesion of oxLDL-treated macrophages to endothelium.
    Wu CC; Wang SH; Kuan II; Tseng WK; Chen MF; Wu JC; Chen YL
    J Cell Biochem; 2009 Jun; 107(3):460-72. PubMed ID: 19308997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relations between autoantibodies against oxidized low-density lipoprotein, inflammation, subclinical atherosclerosis, and cardiovascular disease in rheumatoid arthritis.
    Peters MJ; van Halm VP; Nurmohamed MT; Damoiseaux J; Tervaert JW; Twisk JW; Dijkmans BA; Voskuyl AE
    J Rheumatol; 2008 Aug; 35(8):1495-9. PubMed ID: 18597411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular neutral endopeptidase inhibition improves endothelial function and reduces intimal hyperplasia.
    Barber MN; Kanagasundaram M; Anderson CR; Burrell LM; Woods RL
    Cardiovasc Res; 2006 Jul; 71(1):179-88. PubMed ID: 16635483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelin-1 synthesis and endothelin B receptor expression in human coronary artery smooth muscle cells and monocyte-derived macrophages is up-regulated by low density lipoproteins.
    Haug C; Schmid-Kotsas A; Zorn U; Schuett S; Gross HJ; Gruenert A; Bachem MG
    J Mol Cell Cardiol; 2001 Sep; 33(9):1701-12. PubMed ID: 11549348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of plasma oxidized low-density lipoprotein removal on atherosclerosis.
    Ishigaki Y; Katagiri H; Gao J; Yamada T; Imai J; Uno K; Hasegawa Y; Kaneko K; Ogihara T; Ishihara H; Sato Y; Takikawa K; Nishimichi N; Matsuda H; Sawamura T; Oka Y
    Circulation; 2008 Jul; 118(1):75-83. PubMed ID: 18559699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced oxidation protein products accelerate atherosclerosis through promoting oxidative stress and inflammation.
    Liu SX; Hou FF; Guo ZJ; Nagai R; Zhang WR; Liu ZQ; Zhou ZM; Zhou M; Xie D; Wang GB; Zhang X
    Arterioscler Thromb Vasc Biol; 2006 May; 26(5):1156-62. PubMed ID: 16497990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.